Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

The American Cancer Society estimates more than 20,000 Arkansans will be diagnosed with some form of cancer this year. Cancer ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at the global ASCO® 2026 Genitourinary (GU) Cancers Symposium meeting this ...

Don Bryant, Indiana resident, U.S. Army veteran, and prostate cancer survivor who received treatment with Pluvicto™ therapy in clinical trial Philip Low, Purdue Institute for Cancer Research member, ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...

Doug pedals fast, feeling the exhilaration of speeding along a bike track as his heart rate rises and he starts to breathe harder. Since being diagnosed with stage 4 metastatic prostate cancer in ...